How about sprooking the huge potential of Artimist to the stock market.........in a few weeks when results are in.In the meanwhile I might do a bit of blatent sprooking and upramping on hc. Artimist is using the best (most common) treatment for malaria and changing the delivery system.As I understand by spraying artemisinin under the tongue the drug only has to do battle with some mouth enzymes.The normal path requires the drug to pass through the stomach and the liver during which it is severely affected.A cleaner,sharper and quicker response is expected by sublingual delivery.....with many drugs. The tests have shown it works and we wait for phase 3 results. If in the treatment of malaria the activation time and relative potency of the active ingredience artemisinin is important then a sublingual delivery system could be a major tool in the fight against one of the worlds biggest health problems. While Malaria is largly a 3rd world problem the movement of people broadens risk,including us here in Australia.The recent dangue fever outbreaks in the North,the Ross River outbreaks and other regular outbreaks of mosquito carried diseases means it is for all our benefits we find ways to combat malaria.
U would like to hear what others have to say about the science,other malaria treatments etc.A contary view(with something to say) is welcomed.
On the "going to Market" side thats a marketing exercise for whoever buys Artimist.The usual factors of cost/ benefits come into play when dealing with different 1st world Governments.However given this is largly at present a 3rd world disease and treatment is often rudamentry a more affective,faster working treatment that is easily administered and monitored might just look the goods for 3rd world Govt and doctors.
Looks a low market cap for such a high potential treatment at such a late stage of developement.
EMS Price at posting:
3.0¢ Sentiment: Hold Disclosure: Held
